文献速递艾滋病与性传播感染

ART前HIV-1 DNA与基线病毒免疫状态及一线ART结局相关

Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART.
PubMed 文献 · J Antimicrob Chemother · 2018-01-01

结果显示ART前HIV DNA与HIV RNA、CD4计数等 correlated,且高HIV DNA者病毒学应答率更低、反弹风险更高。

要点

  • 高HIV DNA与24个月病毒学反弹风险增加相关,调整后HR支持该关联。

核心结论

  • ART前HIV DNA可与HIV RNA和CD4计数一起作为新的分期标志,识别病毒学抑制后反弹风险较低或较高的人群。

研究设计与样本

  • ART前HIV DNA用改良COBAS TaqMan HIV-1 Test定量,并按CD4+ T细胞归一化。

主要发现

  • ART前HIV DNA与HIV RNA(R2=+0.44,P<0.0001)、CD4+ T细胞(R2=-0.58,P<0.0001)、CD4/CD8比值(R2=-0.48,P<0.0001)相关。
  • 与CD8+ T细胞(R2=-0.20,P=0.01)、IL-6(R2=+0.16,P=0.002)、可溶性CD14(R2=+0.09,P=0.05)相关性较弱。

关键数值与推荐

  • 病毒学应答定义为HIV RNA≤50 copies/mL。
  • 病毒学反弹定义为HIV RNA>50 copies/mL。
  • 所有病毒学反弹定义的调整HR均支持上述发现(P≤0.02)。

临床怎么用

  • 可考虑检测ART前HIV DNA,联合HIV RNA和CD4计数评估病毒学抑制后反弹风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We evaluated the association between pre-ART HIV DNA and HIV-infected participant characteristics at baseline as well as with their response to first-line ART. METHODS: Four hundred and thirty-three patients from the ICONA cohort, starting first-line ART after the year 2000, were analysed. Pre-ART HIV DNA was quantified with the modified COBAS TaqMan HIV-1 Test and normalized by CD4+ T cells. Linear correlation between pre-ART HIV DNA and other continuous markers (HIV RNA, CD4 count, markers of inflammation and coagulation) at baseline was evaluated by means of Pearson correlation coefficient and a linear regression model. Survival analyses and Cox regression models were used to study the association between pre-ART HIV DNA and time to viro-immunoclinical events. RESULTS: Pre-ART HIV DNA [median (IQR): 10 702 (3397-36 632) copies/106 CD4+ T cells] was correlated with pre-ART HIV RNA [R2 = +0.44, (P < 0.0001)], CD4+ T cells [R2 = -0.58, (P < 0.0001)] and CD4/CD8 ratio [R2 = -0.48, (P < 0.0001)], while weaker correlations were observed with CD8+ T cells (R2 = -0.20, P = 0.01), IL-6 (R2 = +0.16, P = 0.002) and soluble CD14 (R2 = +0.09, P = 0.05). Patients with higher pre-ART HIV DNA showed lower rate and delayed virological response (defined as HIV RNA ≤50 copies/mL), compared with those having lower HIV DNA (67.2% for >10 000, 81.1% for 1000-10 000 and 86.4% for 10-1000 copies/106 CD4+ T cells; P = 0.0004). Higher pre-ART HIV DNA was also correlated with increased risk of virological rebound (defined as HIV RNA >50 copies/mL) by 24 months (17.2% for >10 000, 7.4% for 1000-10 000 and 4.3% for 10-1000 copies/106 CD4+ T cells; P = 0.0048). Adjusted HRs of all virological rebound definitions confirmed these findings (P ≤ 0.02). CONCLUSIONS: Pre-ART HIV DNA, along with HIV RNA and CD4+ T cell count, should be considered as a new staging marker to better identify people at lower (or higher) risk of viral rebound following achievement of virological suppression (≤50 copies/mL).

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Ceccherini-Silberstein F, Cozzi Lepri A, Alteri C, et al. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART. J Antimicrob Chemother. 2018. PMID: 30247724. doi:10.1093/jac/dky350

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。